Value
6.3/10data confidence 83%| Component | Sub-score |
|---|---|
| P/S | 8.5 |
| EV/EBITDA | 0.0 |
| Fwd P/E | 8.8 |
| PEG | 10.0 |
| Analyst target | 4.0 |
- ▸Forward P/E: 12.7x
- ▸PEG: 0.00
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Teleflex is a medical-device company with 29% growth, rising earnings estimates and strong momentum, but at $136.29 the price is already 1.7% above the $133.98 analyst target and quality is only 4.5/10 with 15% short interest.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
| Pillar | Expectation | Trend |
|---|---|---|
Quality is mixed, with a Piotroski F-Score of 8/9 but only moderate margins (FCF margin 8%, FCF yield 3.1%) and a debt-to-equity of 1.0. Quality breakdown | FCF margin should rise above 10% and Piotroski should hold at 7 or higher over 12 months. | →Stable |
| CounterLeverage and moderate cash margins limit flexibility, and quality scores 4.5 overall. | ||
The company is growing 29% YoY and ranks as an industry growth leader, with the growth score at 9.8/10. Growth breakdown | Growth should stay above 15% YoY, with quarterly revenue holding near the $565M estimate. | →Stable |
| CounterReported quarterly revenue is flat around $550-570M, and the data flags large divergences between filing and provider revenue, so the growth figure may be unreliable. | ||
EPS beat estimates in 3 of the last 4 quarters, including 1.76 vs 1.28 in August 2026, and earnings estimates are trending up. Earnings | EPS should continue to meet or beat consensus, including the report due 2026-11-05. | →Stable |
| CounterThe February 2026 quarter missed badly (1.93 vs 3.75), so one quarter can erase the streak. | ||
The $136.29 price is 1.7% above the $133.98 analyst target, so analysts see no upside and downside to the stop is 10.4%. Bear case | The analyst target should rise above $136.29 as estimates move up, or price should consolidate over the next two quarters. | →Stable |
| CounterEstimates are rising and targets tend to follow, so the gap may close from the target side rather than the price side. | ||
Momentum is strong at 6.9/10, with RSI 76 (overbought), rising on-balance volume and price above the 200-day average, while the put/call ratio is 1.70 and short interest is 15%. Momentum breakdown | Momentum score should hold above 5.5 while RSI cools from 76 without a break below the 200-day average. | ↑Improving |
| CounterAn overbought RSI of 76 often precedes a pullback, and elevated put volume with 15% short interest suggests informed bearish positioning. | ||
CounterLeverage and moderate cash margins limit flexibility, and quality scores 4.5 overall.
CounterReported quarterly revenue is flat around $550-570M, and the data flags large divergences between filing and provider revenue, so the growth figure may be unreliable.
CounterThe February 2026 quarter missed badly (1.93 vs 3.75), so one quarter can erase the streak.
CounterEstimates are rising and targets tend to follow, so the gap may close from the target side rather than the price side.
CounterAn overbought RSI of 76 often precedes a pullback, and elevated put volume with 15% short interest suggests informed bearish positioning.
| Component | Sub-score |
|---|---|
| P/S | 8.5 |
| EV/EBITDA | 0.0 |
| Fwd P/E | 8.8 |
| PEG | 10.0 |
| Analyst target | 4.0 |
| Component | Sub-score |
|---|---|
| ROE | 0.0 |
| ROA | 1.2 |
| Gross margin | 7.0 |
| Op margin | 4.0 |
| Net margin | 0.0 |
| Current ratio | 8.8 |
| FCF quality | 5.1 |
| Moat | 5.8 |
| Piotroski F | 8.9 |
| Component | Sub-score |
|---|---|
| Rev growth | 9.7 |
| EPS growth | 10.0 |
| Component | Sub-score |
|---|---|
| RSI | 3.9 |
| MACD | 10.0 |
| OBV | 10.0 |
| MA position | 9.0 |
| Volume | 2.8 |
| Component | Sub-score |
|---|---|
| Analyst rating | 7.0 |
| Price target | 6.6 |
| erm sentiment | 6.2 |
| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 9.2 |
| notable moves | 5.0 |
| Component | Sub-score |
|---|---|
| value rank | 5.4 |
| quality rank | 1.6 |
| growth rank | 8.9 |
| Component | Sub-score |
|---|---|
| bollinger | 0.6 |
| support resistance | 0.7 |
| 52w position | 9.2 |
| Component | Sub-score |
|---|---|
| short interest | 1.9 |
| days to cover | 5.6 |
| volatility | 6.0 |
| put call | 2.0 |
| implied vol | 3.6 |
| beta | 8.0 |
| debt equity | 5.0 |
| Component | Sub-score |
|---|---|
| erm | 6.5 |
| earnings history | 6.7 |
| earnings timing | 5.0 |
| surprise avg | 4.0 |
| dividend safety | 5.8 |
Mixed signals. Hold existing position.
L4:PATH_F_HOLD_DEFAULTSetup— — No clear chart pattern; technical signals are mixed
EdgeNo clear edge — No clear edge identified
SuitabilityModerate — Balanced profile
The default F-path HOLD fired without any positive-conviction gate triggering — no momentum acceleration, no quality+value crossover, no setup recognition. Highest-clear gate: MOMENTUM:7.1>=5.5. Top dim: Growth at 9.8; weakest: Technical at 3.5. The engine's read is one of pattern absence — no directional conviction in either direction at current asymmetry.
The strongest dimensions are Growth at 9.8, Momentum at 7.1, and Sentiment at 6.7; the weakest are Technical at 3.5, Peer rank at 4.2, and Quality at 4.5. The V9 engine flagged 2 failed gates with 1 warning, producing an asymmetric reward-to-risk of -0.30 and an engine sizing output of AVOID.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
Trip ifYoY growth falls below 10% from the current 29%.
Trip ifEPS misses estimates in the 2026-11-05 report and in at least 1 of the next 2 quarters.
Trip ifPrice stays above the analyst target by more than 5% for 2 consecutive quarters without a target increase.
Trip ifPiotroski F-Score drops below 6 from the current 8, or FCF margin falls below 5% from 8%.
Trip ifPrice falls below the $129.73 stop-loss, with momentum score under 5.0 from the current 6.9.